A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomasXing Liu, Yinyan Wang, Yiming Li et al.|NeuroImage Clinical|2018Cited by 262
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signatureYiming Li, Tao Jiang, Xing Liu et al.|European Radiology|2018Cited by 122
Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in GlioblastomaKai Huang, Chunsheng Kang, Xing Liu et al.|Advanced Science|2019Cited by 106
IDH mutation-specific radiomic signature in lower-grade gliomasXing Liu, Yinyan Wang, Yiming Li et al.|Aging|2019Cited by 50
Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival predictionZenghui Qian, Yinyan Wang, Yiming Li et al.|Aging|2018Cited by 40